by Brinette Holdren | Aug 11, 2023 | Articles
In the highly competitive and rapidly evolving biopharma industry, choosing the right contract development and manufacturing organization (CDMO) is a critical decision that can significantly impact the success of a pharmaceutical development journey. When exploring...
by Brinette Holdren | Jul 31, 2023 | News and Events
Taiwan, 31st July 2023: Bora Pharmaceuticals, a leading contract development and manufacturing organization (CDMO), is pleased to announce the opening of a new state-of-the-art facility in Taoyuan City, Taiwan. Officially opened by Bora Pharmaceuticals CEO Bobby Sheng...
by Brinette Holdren | Jul 20, 2023 | News and Events
Bora has been awarded “Outstanding Company of the Year” by an independent panel of international judges during Bio-Asia Taiwan exhibit taking place in Taipei, Taiwan July 24-26, 2023. Bora was chosen from a short list of several candidates for its...
by Brinette Holdren | Jun 22, 2023 | News and Events, Press Mentions
Read Contract Pharma – “What are 3 Key Trends shaping the CDMO industry in 2023 and beyond?” Published on June 22, 2023 Bobby Sheng sheds some light on the three main trends impacting CDMOs in 2023 – and potentially for many years ahead. One...
by Brinette Holdren | May 24, 2023 | News and Events, Press Mentions
In this article, Bora discusses its expansion efforts and plans to provide services in the United States. In the large molecule space, Bora offers comprehensive services from the development of mammalian cell lines through cGMP production of drug substance. Read the...